Thangaratinam S, Ismail K M K, Sharp S, Coomarasamy A, Khan K S
Academic Unit of Obstetrics and Gynaecology, Maternity Block, University Hospital of North Staffordshire, Stoke-on-Trent, UK.
BJOG. 2006 Apr;113(4):369-78. doi: 10.1111/j.1471-0528.2006.00908.x.
Pre-eclampsia is one of the largest causes of maternal and fetal mortality and morbidity. Hyperuricemia is often associated with pre-eclampsia.
To determine the accuracy with which serum uric acid predicts maternal and fetal complications in women with pre-eclampsia.
Systematic quantitative review of test accuracy studies.
We conducted electronic searches in MEDLINE (1951-2004), EMBASE (1980-2004), the Cochrane Library (2004:4) and the MEDION database to identify relevant articles. A hand-search of selected specialist journals and reference lists of articles obtained was then carried out. There were no language restrictions for any of these searches.
Two reviewers independently selected the articles in which the accuracy of serum uric acid was evaluated to predict maternal and fetal complications of pre-eclampsia.
Data were extracted on study characteristics, quality and accuracy to construct 2 x 2 tables with maternal and fetal complications as reference standard. Summary likelihood ratios for positive (LR+) and negative LR(-) test results are generated for various threshold levels of uric acid.
There were 18 primary articles that met the selection criteria, including a total of 3913 women and forty-one 2 x 2 tables. In women with pre-eclampsia, a positive test result of uric acid greater than or equal to a 350-micromol/l threshold predicted eclampsia with a pooled likelihood ratio (LR) of 2.1 (95% CI 1.4-3.5), while a negative test result had a pooled LR of 0.38 (95% CI 0.18-0.81). For severe hypertension as the outcome measure, the LRs were 1.7 (95% CI 1.3-2.2) and 0.49 (95% CI 0.38-0.64) for positive and negative test results, respectively, and for caesarean section the LRs were 2.4 (95% CI 1.3-4.7) and 0.39 (95% CI 0.20-0.76). For stillbirths and neonatal deaths the respective LRs were 1.5 (95% CI 0.91-2.6) and 0.51 (95% CI 0.20-1.3). For the prediction of small-for-gestational-age fetus, the pooled LRs were 1.3 (95% CI 1.1-1.7) and 0.60 (95% CI 0.43-0.83) for positive and negative results, respectively. AUTHOR'S CONCLUSION: Serum uric acid is a poor predictor of maternal and fetal complications in women with pre-eclampsia.
子痫前期是孕产妇和胎儿死亡及发病的主要原因之一。高尿酸血症常与子痫前期相关。
确定血清尿酸预测子痫前期女性孕产妇和胎儿并发症的准确性。
对检测准确性研究进行系统定量综述。
我们在MEDLINE(1951 - 2004年)、EMBASE(1980 - 2004年)、Cochrane图书馆(2004年第4期)和MEDION数据库中进行电子检索,以识别相关文章。然后对选定的专业期刊和所获文章的参考文献列表进行手工检索。这些检索均无语言限制。
两名评审员独立选择评估血清尿酸预测子痫前期孕产妇和胎儿并发症准确性的文章。
提取有关研究特征、质量和准确性的数据,以孕产妇和胎儿并发症作为参考标准构建2×2表格。针对尿酸的不同阈值水平,生成阳性(LR +)和阴性(LR -)检测结果的汇总似然比。
有18篇主要文章符合入选标准,共纳入3913名女性,形成41个2×2表格。在子痫前期女性中,尿酸检测结果阳性(大于或等于350微摩尔/升阈值)预测子痫的汇总似然比(LR)为2.1(95%可信区间1.4 - 3.5),而阴性检测结果的汇总LR为0.38(95%可信区间0.18 - 0.81)。以重度高血压作为结局指标,阳性和阴性检测结果的LR分别为1.7(95%可信区间1.3 - 2.2)和0.49(95%可信区间0.38 - 0.64);以剖宫产作为结局指标,LR分别为2.4(95%可信区间1.3 - 4.7)和0.39(95%可信区间0.20 - 0.76)。对于死产和新生儿死亡,各自的LR分别为1.5(95%可信区间0.91 - 2.6)和0.51(95%可信区间0.20 - 1.3)。对于小于胎龄儿的预测,阳性和阴性结果的汇总LR分别为1.3(95%可信区间1.1 - 1.7)和0.60(95%可信区间0.43 - 0.83)。
血清尿酸在预测子痫前期女性孕产妇和胎儿并发症方面表现不佳。